Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

388
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
388
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

279
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
279
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

692
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
692
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

279
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
279
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

244
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
244

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026
Same author

Soil-transmitted helminth infections among migrants and travelers: a 10-year retrospective study.

Tropical medicine and health·2026
Same author

Ten years of Plasmodium malariae infections in an International Health Reference Center in Barcelona: temporal trends and insights.

Malaria journal·2026
Same author

Systemic sclerosis and cardiovascular disease: an integrative perspective on immune-vascular mechanisms and emerging risk stratification strategies.

Rheumatology international·2026
Same author

Descriptive Analysis of Imported Toxocariasis Cases Diagnosed Between 2014 and 2024 in an International Health Unit in Barcelona, Spain.

Tropical medicine & international health : TM & IH·2026
Same author

Safety and tolerability of benznidazole in older patients with chronic Chagas disease.

Travel medicine and infectious disease·2026
Same journal

Severe hyperkalaemia during liposomal amphotericin B treatment, independent of nephrotoxicity.

European journal of internal medicine·2026
Same journal

Cardiovascular complications of antineoplastic treatment in prostate cancer patients and compensatory strategies for clinical management.

European journal of internal medicine·2026
Same journal

Artificial intelligence and clinical responsibility in the multimorbid patient.

European journal of internal medicine·2026
Same journal

Risk reclassification and implementation challenges in the 2026 AHA/ACC pulmonary embolism guideline.

European journal of internal medicine·2026
Same journal

Recurrent Pericarditis, Hydroxychloroquine, and the Unrecognized Risk of Myasthenia Gravis.

European journal of internal medicine·2026
Same journal

Aldosterone synthase inhibitors in uncontrolled and resistant hypertension: promise, pitfalls, and unanswered questions.

European journal of internal medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K

ANCA associated vasculitis.

Fernando Salvador1

  • 1Autoimmune Diseases Unit, Internal Medicine Department, Centro Hospitalar de Trás-os-Montes e Alto Douro, Avenida da Noruega, 5000-508 Vila Real, Portugal; NEDAI/SPMI Autoimmune Diseases Group/Portuguese Society of Internal Medicine, Portugal.

European Journal of Internal Medicine
|February 2, 2020
PubMed
Summary
This summary is machine-generated.

Vasculitis, an inflammation of blood vessels, presents complex symptoms affecting multiple systems. Early diagnosis and a systematic treatment approach significantly improve survival rates for this condition.

Keywords:
Anti-neutrophil cytoplasmic antibody-associated vasculitisAutoimmune diseasesChurg-Strauss syndromeGranulomatosis with polyangiitisMicroscopic polyangiitis

More Related Videos

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.5K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K
Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.5K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.5K

Area of Science:

  • Immunology
  • Rheumatology
  • Internal Medicine

Background:

  • Vasculitis involves inflammation of the vascular wall, leading to multisystemic complications.
  • Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) affects 20 per million annually, driven by infectious, genetic, and environmental factors.
  • AAV symptoms are varied and unspecific, frequently impacting general health, respiratory, and renal systems.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for vasculitis.
  • To emphasize the importance of a holistic and systematized approach to managing vasculitis.
  • To highlight the impact of appropriate management on patient survival rates.

Main Methods:

  • Diagnosis relies on a combination of clinical evaluation, laboratory tests, imaging, and histological findings.
  • Treatment decisions are guided by disease classification, extent, and severity.
  • Therapeutic options include glucocorticoids, methotrexate for localized disease, and cyclophosphamide, rituximab, or azathioprine for generalized disease.

Main Results:

  • A comprehensive diagnostic approach is crucial for effective vasculitis management.
  • Tailored therapeutic strategies based on disease presentation are essential.
  • A systematized approach to vasculitis management can dramatically increase 5-year survival rates from 12% to 70%.

Conclusions:

  • Vasculitis requires a multidisciplinary and holistic approach for optimal patient outcomes.
  • Accurate diagnosis and classification are paramount for selecting appropriate therapies.
  • Systematic management significantly enhances survival in patients with vasculitis.